Health and Fitness FDA Approves Perjeta for Neoadjuvant Breast Cancer Treatment by Gary Kopycinski on September 30, 2013 Gary Kopycinski Author More in Health and Fitness: On Hantavirus, Park Forest Officials Urge Caution May 18, 2026 Rep. Kelly Condemns FDA Approval of Flavored E-Cigarettes May 6, 2026 Park Forest Aligns With Illinois Guidance on Childhood Vaccines Amid Federal Changes January 11, 2026 First drug approved for use in preoperative breast cancer